Molecular insights into systemic sclerosis-associated interstitial lung disease

Arthritis and Rheumatology

Volumn 66, Issue 3, 2014, Pages 485-487

  Silver, Richard M ^a   Feghali Bostwick, Carol A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CHEMOKINE; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE RICH PROTEIN 61; INTERFERON; MATRILYSIN; TRANSFORMING GROWTH FACTOR BETA;

CLINICAL PRACTICE; DISEASE ASSOCIATION; DISEASE DURATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION TEST; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; REVIEW; SYSTEMIC SCLEROSIS; FEMALE; GENETICS; LUNG; LUNG FIBROSIS; MALE; METABOLISM; NOTE;

FEMALE; HUMANS; LUNG; MACROPHAGE ACTIVATION; MALE; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC;

EID: 84896283016     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38287     Document Type: Review

References (14)

1. Christmann RB, Sampaio-Barros P, Stifano G, Borges CL, de Carvalho CR, Kairalla R, et al. Association of interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis. Arthritis Rheumatol 2014;66:714-25.
2. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-4.
3. Daoussis D, Liossis SN, Tsamandas AC, Kalogeropoulou C, Paliogianni F, Sirinian C, et al. Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis. Clin Exp Rheumatol 2012;30:S17-22.
4. Khanna D, Tseng CH, Farmani N, Steen V, Furst DE, Clements PJ, et al. Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study placebo group. Arthritis Rheum 2011;63:3078-85.
5. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006;354:2655-66.
6. Kinsella MB, Smith EA, Miller KS, LeRoy EC, Silver RM. Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma. Arthritis Rheum 1989;32:577-83.
7. Kowal-Bielecka O, Kowal K, Highland KB, Silver RM. Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature. Semin Arthritis Rheum 2010;40:73-88.
8. Andersen GN, Nilsson K, Nagaeva O, Rantapaa-Dahlqvist S, Sandstrom T, Mincheva Nilsson L. Cytokine mRNA profile of alveolar T lymphocytes and macrophages in patients with systemic sclerosis suggests a local Tr1 response. Scand J Immunol 2011;74: 272-81.
9. Ludwicka A, Ohba T, Trojanowska M, Yamakage A, Strange C, Smith EA, et al. Elevated levels of platelet derived growth factor and transforming growth factor-β1 in bronchoalveolar lavage fluid from patients with scleroderma. J Rheumatol 1995;22:1876-83.
10. Hsu E, Shi H, Jordan RM, Lyons-Weiler J, Pilewski JM, Feghali- Bostwick CA. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheum 2011;63:783-94.
11. Lindahl GE, Stock CJ, Shi-Wen X, Leoni P, Sestini P, Howat SL, et al. Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease. Respir Res 2013;14:80.
12. Steen V, Domsic RT, Lucas M, Fertig N, Medsger TA Jr. A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis. Arthritis Rheum 2012;64: 2986-94.
13. Bogatkevich GS, Ludwicka-Bradley A, Highland KB, Hant F, Nietert PJ, Singleton CB, et al. Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis. Arthritis Rheum 2007;56:2432-42.
14. Brissett M, Veraldi KL, Pilewski JM, Medsger TA Jr, Feghali- Bostwick CA. Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3. Arthritis Rheum 2012;64:272-80.